Vascularisation

From Wikipedia, the free encyclopedia
(Redirected from Vascularization)

Template:Short description

Page Module:Infobox/styles.css has no content.

Vascularisation
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
3D medical animation still showing angiogenesis
Biological systemcardiovascular system
ActionInvoluntary
MethodPage Template:Plainlist/styles.css has no content.
  • Vasculogenesis
  • Angiogenesis
  • Arteriogenesis
  • Lymphangiogenesis

Vascularisation or neovascularization (neo- + vascular + -ization) is the physiological process through which blood vessels form in tissues or organs.

Growth factors that inhibit neovascularization include those that affect endothelial cell division and differentiation. These growth factors often act in a paracrine or autocrine fashion; they include fibroblast growth factor, placental growth factor, insulin-like growth factor, hepatocyte growth factor, and platelet-derived endothelial growth factor.[1]

It may occur through angiogenesis (the formation of new blood vessels form from pre-existing ones), vasculogenesis (the creation of blood vessels during development, particularly in embryos) or arteriogenesis (where smaller vessels become enlarged into fully functioning arteries).[2]

Vasculogenesis

Script error: No such module "For". Vasculogenesis is the process of blood vessel formation, occurring by a de novo production of endothelial cells.[3] It is the first stage of the formation of the vascular network, closely followed by angiogenesis.[4][5]

This is the creation of blood vessels during early development particularly in embryos. Blood vessels start to form from special cells known as endothelial progenitor cells. While this process mostly happens during embryonic development, it can also occur in adults when the body needs to repair damaged blood vessels or grow new ones after an injury occurs.[6]

Vasculogenesis is the formation of new blood vessels, in blood islands, which first arise in the mesoderm of the yolk sac at 3 weeks of development,[7] when there are no pre-existing ones.[8] For example, if a monolayer of endothelial cells begins sprouting to form capillaries, angiogenesis is occurring. Vasculogenesis, in contrast, is when endothelial precursor cells (angioblasts) migrate and differentiate in response to local cues (such as growth factors and extracellular matrices) to form new blood vessels. These vascular trees are then pruned and extended through angiogenesis.

Vasculogenesis can also arise in the adult organism from circulating endothelial progenitor cells (derivatives of stem cells). These cells are able to contribute, albeit to varying degrees, to neovascularization. Examples of where vasculogenesis can occur in adults are:

Angiogenesis

Script error: No such module "Labelled list hatnote". It is the process where new blood vessels form from pre-existing ones. This happens naturally when the body needs to repair tissue or when a wound needs to heal. It is driven by signals from growth factors, such as Vascular Endothelial Growth Factor (VEGF), which prompts the formation of new vessels. However, this process can occasionally go wrong in tumour formation where it allows the tumours to create their own blood supply and grow larger, which can contribute to diseases like cancer.[10]

Angiogenesis is the most common type of neovascularization seen in development and growth, and is important to both physiological and pathological processes.[11] Angiogenesis occurs through the formation of new vessels from pre-existing vessels. This occurs through the sprouting of new capillaries from post-capillary venules, requiring precise coordination of multiple steps and the participation and communication of multiple cell types. The complex process is initiated in response to local tissue ischemia or hypoxia, leading to the release of angiogenic factors such as VEGF and HIF-1. This leads to vasodilatation and an increase in vascular permeability, leading to sprouting angiogenesis or intussusceptive angiogenesis.[2]

Arteriogenesis

Script error: No such module "Labelled list hatnote". This is a process where smaller and less efficient blood vessels become enlarged into fully functioning arteries. This usually happens in response to increased demand in the body such as during exercise or when blood vessels are blocked. This aids in ensuring that tissues are supplied with enough blood and oxygen.[12]

Arteriogenesis is the process of flow-related remodelling of existing vasculature to create collateral arteries. This can occur in response to ischemic vascular diseases or increase demand (e.g. exercise training). Arteriogenesis is triggered through nonspecific factors, such as shear stress and blood flow.[2]

Lymphangiogenesis

Script error: No such module "Labelled list hatnote". This process is similar to angiogenesis but involves the creation of lymphatic vessels which are essential for draining excess fluid and fighting infections. This process is also key to conditions like inflammation and the spreading of cancer.[13]

Applications in medicine

Cancer

In cancer, tumours take over the body's vascularisation processes to supply themselves with blood, helping them grow and spread. Anti-angiogenic therapies are currently used in combination with other therapies for cancer management.[14][15][16][17] Bevacizumab, a monoclonal antibody & VEGF inhibitor is approved for use in cancer treatment.[18]

Ocular pathologies

Corneal neovascularization

Script error: No such module "For". Corneal neovascularization is a condition where new blood vessels invade into the cornea from the limbus. It is triggered when the balance between angiogenic and antiangiogenic factors are disrupted that otherwise maintain corneal transparency. The immature new blood vessels can lead to persistent inflammation and scarring, lipid exudation into the corneal tissues, and a reduction in corneal transparency, which can affect visual acuity.[19]

Retinopathy of prematurity

Script error: No such module "For". Retinopathy of prematurity is a condition that occurs in premature babies. In premature babies, the retina has not completely vascularized. Rather than continuing in the normal in utero fashion, the vascularization of the retina is disrupted, leading to an abnormal proliferation of blood vessels between the areas of vascularized and avascular retina. These blood vessels grow in abnormal ways and can invade into the vitreous humor, where they can hemorrhage or cause retinal detachment in neonates.[20]

Diabetic retinopathy

Script error: No such module "For". Diabetic retinopathy is an ocular pathology in diabetics which results in weakening of the retinal blood vessels. The initial nonproliferative stage is characterised by leaky vessels. As the vessel damage is repaired over time, they eventually become occluded, leading to proliferative diabetic retinopathy. The occluded capillaries create areas of ischemic retina and trigger the release of angiogenic growth factors. These growth factors stimulate the proliferation of new blood vessels from pre-existing retinal venules. It is the leading cause of blindness of working age adults.[20][21]

Script error: No such module "For". In persons who are over 65 years old, age-related macular degeneration is the leading cause of severe vision loss. A subtype of age-related macular degeneration, wet macular degeneration, is characterized by the formation of new blood vessels that originate in the choroidal vasculature and extend into the subretinal space.[20]

Choroidal neovascularization

Script error: No such module "For". In ophthalmology, choroidal neovascularization is the formation of a microvasculature within the innermost layer of the choroid of the eye.[22] Neovascularization in the eye can cause a type of glaucoma (neovascularization glaucoma) if the new blood vessels' bulk blocks the constant outflow of aqueous humour from inside the eye.

Cardiovascular diseases

Cardiovascular disease is the leading cause of death in the world.[23] Ischemic heart disease develops when stenosis and occlusion of coronary arteries develops, leading to reduced perfusion of the cardiac tissue. Induction of neovascularization of ischemic cardiac tissues therefore has therapeutic potential.[24][25]

Wound healing

Vascularization is crucial for wound healing, as it provides oxygen and nutrients necessary for tissue repair.[33] Angiogenesis temporarily increases vascular density around the wound, aiding the healing process.[33]

Vascular endothelial growth factor (VEGF) is a key pro-angiogenic factor in this process, stimulating both vasculogenesis and angiogenesis in the skin.[33] Impaired angiogenesis can result in delayed wound healing, as seen in conditions such as diabetes, where chronic wounds often exhibit reduced levels of active VEGF. Therapeutic stimulation of angiogenesis is being explored to speed up healing, especially in persistent wounds.[34][35][36]

See also

References

  1. ^ Page Module:Citation/CS1/styles.css has no content.Neely, Kimberly A.; Gardner, Thomas W. (1998-09-01). "Ocular Neovascularization". The American Journal of Pathology. 153 (3): 665–670. doi:10.1016/S0002-9440(10)65607-6. ISSN 0002-9440. PMC 1852998. PMID 9736014.
  2. ^ a b c Page Module:Citation/CS1/styles.css has no content.Marín-García, José (2007). "11: Cardiac Neovascularization: Angiogenesis, Arteriogenesis, and Vasculogensis". Post-Genomic Cardiology (1 ed.). Academic Press. doi:10.1016/B978-0-12-373698-7.X5000-1. ISBN 978-0-12-373698-7.
  3. ^ Page Module:Citation/CS1/styles.css has no content.John S. Penn (2008). Retinal and Choroidal Angiogenesis. Springer. p. 119. ISBN 978-1-4020-6779-2.
  4. ^ Page Module:Citation/CS1/styles.css has no content.Patan, S (2004). "Vasculogenesis and Angiogenesis". Angiogenesis in Brain Tumors. Cancer Treatment and Research. Vol. 117. pp. 3–32. doi:10.1007/978-1-4419-8871-3_1. ISBN 978-1-4613-4699-9. PMID 15015550.
  5. ^ Page Module:Citation/CS1/styles.css has no content.Dorland's illustrated medical dictionary (32nd ed.). Saunders/Elsevier. 2 May 2011. p. 84. ISBN 9781416062578.
  6. ^ Page Module:Citation/CS1/styles.css has no content.Asahara, Takayuki; Murohara, Toyoaki; Sullivan, Alison; Silver, Marcy; van der Zee, Rien; Li, Tong; Witzenbichler, Bernhard; Schatteman, Gina; Isner, Jeffrey M. (1997-02-14). "Isolation of Putative Progenitor Endothelial Cells for Angiogenesis". Science. 275 (5302): 964–966. doi:10.1126/science.275.5302.964. ISSN 0036-8075. PMID 9020076.
  7. ^ Page Module:Citation/CS1/styles.css has no content.Sadler, T.W. (2011). Medical Embryology, 12th. LWW. p. 75.
  8. ^ Page Module:Citation/CS1/styles.css has no content."Endoderm -- Developmental Biology -- NCBI Bookshelf". Retrieved 2010-04-07.
  9. ^ Page Module:Citation/CS1/styles.css has no content.Laschke, M. W.; Giebels, C.; Menger, M. D. (2011). "Vasculogenesis: A new piece of the endometriosis puzzle". Human Reproduction Update. 17 (5): 628–636. doi:10.1093/humupd/dmr023. PMID 21586449.
  10. ^ Page Module:Citation/CS1/styles.css has no content.Carmeliet, Peter (December 2005). "Angiogenesis in life, disease and medicine". Nature. 438 (7070): 932–936. Bibcode:2005Natur.438..932C. doi:10.1038/nature04478. ISSN 0028-0836. PMID 16355210.
  11. ^ Dudley, A.C. & Griffioen, A.W., Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis, 2023. doi: 10.1007/s10456-023-09876-7
  12. ^ Page Module:Citation/CS1/styles.css has no content.Cai, Weijun; Schaper, Wolfgang (2008-08-01). "Mechanisms of arteriogenesis". Acta Biochimica et Biophysica Sinica. 40 (8): 681–692. doi:10.1093/abbs/40.8.681. ISSN 1672-9145. PMID 18685784.
  13. ^ Page Module:Citation/CS1/styles.css has no content.Alitalo, Kari; Tammela, Tuomas; Petrova, Tatiana V. (2005-12-14). "Lymphangiogenesis in development and human disease". Nature. 438 (7070): 946–953. Bibcode:2005Natur.438..946A. doi:10.1038/nature04480. ISSN 0028-0836. PMID 16355212.
  14. ^ Page Module:Citation/CS1/styles.css has no content.Lopes-Coelho, Filipa; Martins, Filipa; Pereira, Sofia A.; Serpa, Jacinta (2021-04-05). "Anti-Angiogenic Therapy: Current Challenges and Future Perspectives". International Journal of Molecular Sciences. 22 (7): 3765. doi:10.3390/ijms22073765. ISSN 1422-0067. PMC 8038573. PMID 33916438.
  15. ^ Page Module:Citation/CS1/styles.css has no content.Samant, Rajeev S.; Shevde, Lalita A. (2011-03-07). "Recent Advances in Anti-Angiogenic Therapy of Cancer". Oncotarget. 2 (3): 122–134. doi:10.18632/oncotarget.234. ISSN 1949-2553. PMC 3260813. PMID 21399234.
  16. ^ Page Module:Citation/CS1/styles.css has no content."Angiogenesis Inhibitors - NCI". www.cancer.gov. 2018-05-01. Retrieved 2025-04-02.
  17. ^ Page Module:Citation/CS1/styles.css has no content.Saman, Harman; Raza, Syed Shadab; Uddin, Shahab; Rasul, Kakil (2020-05-06). "Inducing Angiogenesis, a Key Step in Cancer Vascularization, and Treatment Approaches". Cancers. 12 (5): 1172. doi:10.3390/cancers12051172. ISSN 2072-6694. PMC 7281705. PMID 32384792.
  18. ^ Page Module:Citation/CS1/styles.css has no content.Ferrara, Napoleone; Kerbel, Robert S. (December 2005). "Angiogenesis as a therapeutic target". Nature. 438 (7070): 967–974. Bibcode:2005Natur.438..967F. doi:10.1038/nature04483. ISSN 0028-0836. PMID 16355214.
  19. ^ Page Module:Citation/CS1/styles.css has no content.Chiang, Homer H.; Hemmati, Houman D. (October 2013). Scott, Ingrid U.; Fekrat, Sharon (eds.). "Treatment of Corneal Neovascularization". EyeNet Magazine. American Academy of Ophthalmology: 35–6. Retrieved 14 July 2020.
  20. ^ a b c Page Module:Citation/CS1/styles.css has no content.Neely, Kimberly A.; Gardner, Thomas W. (September 1998). "Ocular Neovascularization: Clarifying Complex Interactions". The American Journal of Pathology. 153 (3). Elsevier Inc.: 665–670. doi:10.1016/S0002-9440(10)65607-6. PMC 1852998. PMID 9736014. Retrieved 14 July 2020.
  21. ^ Page Module:Citation/CS1/styles.css has no content.Suh, D. Y. (2000-07-01). "Understanding angiogenesis and its clinical applications". Annals of Clinical and Laboratory Science. 30 (3): 227–238. ISSN 0091-7370. PMID 10945562.
  22. ^ Page Module:Citation/CS1/styles.css has no content.Reddy U, Krzystolik M (2006). "Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration". Cochrane Database Syst Rev (1) CD005138. doi:10.1002/14651858.CD005138.pub2. PMC 12276864. PMID 16437522.
  23. ^ Page Module:Citation/CS1/styles.css has no content."Cardiovascular diseases (CVDs)". World Health Organization. 17 May 2017. Retrieved 14 July 2020.
  24. ^ Page Module:Citation/CS1/styles.css has no content.Lassaletta, Antonio D.; Chu, Louis M.; Sellke, Frank W. (November 2011). "Therapeutic neovascularization for coronary disease: current state and future prospects". Basic Research in Cardiology. 106 (6): 897–909. doi:10.1007/s00395-011-0200-1. PMID 21713563. S2CID 28038901.
  25. ^ Page Module:Citation/CS1/styles.css has no content.Johnson, Takerra; Zhao, Lina; Manuel, Gygeria; Taylor, Herman; Liu, Dong (7 February 2019). "Approaches to therapeutic angiogenesis for ischemic heart disease". Journal of Molecular Medicine. 97 (2): 141–151. doi:10.1007/s00109-018-1729-3. PMC 6417498. PMID 30554258.
  26. ^ a b Page Module:Citation/CS1/styles.css has no content.Camaré, Caroline; Pucelle, Mélanie; Nègre-Salvayre, Anne; Salvayre, Robert (2017-08-01). "Angiogenesis in the atherosclerotic plaque". Redox Biology. 12: 18–34. doi:10.1016/j.redox.2017.01.007. ISSN 2213-2317. PMC 5312547. PMID 28212521.
  27. ^ Page Module:Citation/CS1/styles.css has no content.Finn, Aloke V.; Jain, Rakesh K. (2010-01-01). "Coronary Plaque Neovascularization and Hemorrhage". JACC: Cardiovascular Imaging. 3 (1): 41–44. doi:10.1016/j.jcmg.2009.11.001. PMC 2842010. PMID 20129529.
  28. ^ Page Module:Citation/CS1/styles.css has no content.Li, Na; Rignault-Clerc, Stephanie; Bielmann, Christelle; Bon-Mathier, Anne-Charlotte; Déglise, Tamara; Carboni, Alexia; Ducrest, Mégane; Rosenblatt-Velin, Nathalie (2020-11-27). "Increasing heart vascularisation after myocardial infarction using brain natriuretic peptide stimulation of endothelial and WT1+ epicardial cells". eLife. 9 e61050. doi:10.7554/eLife.61050. ISSN 2050-084X. PMC 7695454. PMID 33245046.
  29. ^ Page Module:Citation/CS1/styles.css has no content.Niu, Hong; Liu, Zhongting; Guan, Ya; Dang, Yu; Guan, Jianjun (2023-08-04). "Abstract P2133: Preservation & Vascularization Of Cardiac Extracellular Matrix After Acute Myocardial Infarction". Circulation Research. 133 (Suppl_1): AP2133. doi:10.1161/res.133.suppl_1.P2133.
  30. ^ Page Module:Citation/CS1/styles.css has no content.Liu, Jialing; Wang, Yongting; Akamatsu, Yosuke; Lee, Chih Cheng; Stetler, R. Anne; Lawton, Michael T.; Yang, Guo-Yuan (2014-04-01). "Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials". Progress in Neurobiology. 115: 138–156. doi:10.1016/j.pneurobio.2013.11.004. ISSN 1873-5118. PMC 4295834. PMID 24291532.
  31. ^ Page Module:Citation/CS1/styles.css has no content.Freitas-Andrade, Moises; Raman-Nair, Joanna; Lacoste, Baptiste (2020-08-07). "Structural and Functional Remodeling of the Brain Vasculature Following Stroke". Frontiers in Physiology. 11 948. doi:10.3389/fphys.2020.00948. ISSN 1664-042X. PMC 7433746. PMID 32848875.
  32. ^ Page Module:Citation/CS1/styles.css has no content.Zhu, Hua; Zhang, Yonggang; Zhong, Yi; Ye, Yingze; Hu, Xinyao; Gu, Lijuan; Xiong, Xiaoxing (2021-04-21). "Inflammation-Mediated Angiogenesis in Ischemic Stroke". Frontiers in Cellular Neuroscience. 15 652647. doi:10.3389/fncel.2021.652647. ISSN 1662-5102. PMC 8096981. PMID 33967696.
  33. ^ a b c Page Module:Citation/CS1/styles.css has no content.Johnson, Kelly E.; Wilgus, Traci A. (2014-10-01). "Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair". Advances in Wound Care. 3 (10): 647–661. doi:10.1089/wound.2013.0517. ISSN 2162-1918. PMC 4183920. PMID 25302139.
  34. ^ Page Module:Citation/CS1/styles.css has no content.Huang, Kang; Mi, Bobin; Xiong, Yuan; Fu, Zicai; Zhou, Wenyun; Liu, Wanjun; Liu, Guohui; Dai, Guandong (2025-01-01). "Angiogenesis during diabetic wound repair: from mechanism to therapy opportunity". Burns & Trauma. 13 tkae052. doi:10.1093/burnst/tkae052. ISSN 2321-3876. PMC 11802347. PMID 39927093.
  35. ^ Page Module:Citation/CS1/styles.css has no content.Akita, Sadanori (2019-12-15). "Wound Repair and Regeneration: Mechanisms, Signaling". International Journal of Molecular Sciences. 20 (24): 6328. doi:10.3390/ijms20246328. ISSN 1422-0067. PMC 6940902. PMID 31847465.
  36. ^ Page Module:Citation/CS1/styles.css has no content.Veith, Austin P.; Henderson, Kayla; Spencer, Adrianne; Sligar, Andrew D.; Baker, Aaron B. (2019-06-01). "Therapeutic strategies for enhancing angiogenesis in wound healing". Advanced Drug Delivery Reviews. 146: 97–125. doi:10.1016/j.addr.2018.09.010. ISSN 1872-8294. PMC 6435442. PMID 30267742.

Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found.

Retrieved from "https://cosmopedia.co/index.php?title=Vascularisation&oldid=10327718"